System Designed to Reduce the Incidence of Positive Margins – or Cancer Left Behind - After Breast Cancer Surgery
The Breast Cancer Locator™ from Cairn Surgical has been named the 2021 Product of the Year by the NH Tech...
Clinical Study to Evaluate System’s Ability to Reduce Positive Margin Rate. The first patient has been treated in the pivotal...
Celdara Medical, LLC today announced that the first DRIVEN Accelerator Hub Participant Company, CairnSurgical, Inc., has closed a Series A...
Yes, because all patients’ cases vary, each BCL™ is made “Just in time” for each patient.
By capturing the exact patient anatomy in the surgical position (supine) MRI, the surgeon is able to accurately visualize their surgical field in an augmented 3D view using Visualizer™ . At the time of surgery, such anatomic information is accurately transferred onto the patient’s breast using a patient-specific form called the BCL™ .
1. The BCL™ device may decrease the positive margin rate by delineating the tumor edges
2. It may decrease the volume of breast tissue removed during surgery.
3. It removes the need for additional wire localization immediately before surgery.
4. It provides 3D visualization of cancers in the breast that allows investigators to observe their relationship to the skin and chest wall and places bracketing wires that offer additional guidance to surgeons beyond the standard wire localization.
The BCL™ is created using a 3D printing process involving a digital model that is derived from the patient’s supine MRI data. The BCL™ device itself is made from a photopolymer resin material. Each device is custom-made for an individual patient. Utilizing the custom device and the technology during surgery may decrease the positive margin rate, potentially leading to less need for re-excision surgery.
The Breast Cancer Locator™ (BCL™) is a 3-D printed surgical guide that assists surgeons with the tumor’s size, orientation, and shape.